Evidence map›Paper›PMID 36207044›Full record

ArticleBMJ open2022

Association between serum alkaline phosphatase and bacteraemia in haemodialysis outpatients: a multicentre retrospective cross-sectional study.

Aya Katasako, Sho Sasaki, Yoshihiko Raita, Shungo Yamamoto, Kentaro Tochitani, Minoru Murakami, Ryo Nishioka, Kiichiro Fujisaki

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Aya Katasako *Department of Nephrology, Iizuka Hospital, Iizuka, Fukuoka, Japan.ORCID 0000-0002-0315-1395
Sho Sasaki *Department of Nephrology, Iizuka Hospital, Iizuka, Fukuoka, Japan sasaki.sho.3f@kyoto-u.ac.jp.
Yoshihiko RaitaDepartment of Nephrology, Okinawa Chubu Hospital, Uruma, Japan.
Shungo YamamotoDepartment of Transformative Infection Control Development Studies, Osaka University Graduate School of Medicine, Osaka, Japan.
Kentaro TochitaniDepartment of Healthcare Epidemiology, Kyoto University Graduate School of Public Health, Kyoto, Japan.
Minoru MurakamiDepartment of Nephrology, Saku Central Hospital, Saku, Japan.ORCID 0000-0003-0435-7106
Ryo NishiokaDepartment of Rheumatology, Kanazawa University Hospital, Kanazawa, Japan.
Kiichiro FujisakiDepartment of Nephrology, Iizuka Hospital, Iizuka, Fukuoka, Japan.
Aso Iizuka Hospital · JPKyoto University · JPKanazawa University Hospital · JPOkinawa Prefectural Chubu Hospital · JPOsaka University Hospital · JPSaku Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesElevated baseline serum alkaline phosphatase (ALP) may correlate with higher medium-term to long-term mortality in the general population and in patients with chronic kidney disease. However, few data are available on the association between serum ALP and the short-term prognosis of patients on haemodialysis (HD). We verified the association of ALP levels and bacteraemia or death in maintenance HD patients suspected of bacteraemia in an outpatient setting.

designWe analysed 315 consecutive HD patients suspected of having bacteraemia with two sets of blood culture drawn on admission.

settingAdmission to two tertiary-care university medical centres from January 2013 to December 2015.

participantsConsecutive cases on maintenance HD aged≥18 years. Cases of hospitalised patients who had been transferred from another hospital, had a dialysis vintage<2 months, were also undergoing peritoneal dialysis, and/or were receiving HD less than once a week were excluded. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome measure was bacteraemia and secondary outcome was in-hospital death.

resultsAmong 315 cases included in the study, 187 had baseline-measured ALP levels, with a cut-off value on ROC analysis of 360 U/L (Area Under the Curve (AUC) 0.60, sensitivity 0.49, specificity 0.76). In multivariate analysis, there was a statistically significant association between a higher ALP in hospital visit and bacteraemia (OR: 2.37, 95% CI: 1.17 to 4.83). However, there were no statistically significant associations between higher ALP and in-hospital death (OR: 1.20, 95% CI: 0.57 to 2.54). A sensitivity analysis of 187 patients with no missing ALP values also demonstrated a significant association between elevated ALP and bacteraemia, but no significant association between ALP and in-hospital death.

conclusionsElevated ALP is a predictor of bacteraemia. In HD patients suspected of bacteraemia in outpatient settings, increased ALP levels were associated with increased likelihood of confirmed disease.

Indexed as

BacteremiaRenal DialysisAlkaline PhosphataseCross-Sectional StudiesHospital MortalityHumansOutpatientsRetrospective StudiesAlkaline Phosphatasedialysisinfectious diseasesnephrology

Identifiers

PMID36207044
PMCPMC9557305
OpenAlexW4303446382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.